SIGA Can't Scrap Smallpox Drug Profit-Share Ruling
A Delaware judge on Friday refused to reconsider an order granting PharmAthene Inc. a share in profits from SIGA Technologies Inc.'s smallpox drug, as part of a ruling that SIGA breached...To view the full article, register now.
Already a subscriber? Click here to view full article